Science blog
Orbital mechanics affect methane levels
Antarctic lake keeps its secrets for now
How snakes lost their legs
Researchers ponder cancer origins
Forming social networks a no-brainer
'Niceness' partly genetic, say scientists
Omega-3 may keep blindness at bay
Coral shines light on rainfall records
Old bone proves Lucy was no swinger
Scientists unlock cosmic ice riddle
Study links pesticides to Parkinson's
Digital world growing faster every year
Energy drinks put kids at risk: report
Robotics speed up cancer drug development
Zinc cuts short the common cold
Counting kicks in at 18 months
NASA spacecraft unravels comet mystery
Astronomers dig up cannibalised galaxy
Study links extreme weather to climate change
Turkey quake gives warning clues
US scientists build first 'antilaser'
Website meltdown leaves scientists fuming
Earth 'unrecognisable' by 2050: experts
Canola fungus genome unravelled
Cancer resistance mechanism found
A newly identified mechanism that helps explain why some tumours are resistant to specific anti-cancer drugs could help improve patient care and drug design.

Chemotherapy drugs, such as Taxol and vincristine, are used to treat certain types of cancers, such as ovarian and breast adenocarcinomas, some types of lung cancer, leukaemias and lymphomas. But in some patients the effectiveness of these drugs is reduced.

Two teams of researchers now believe they have discovered why this is the case.

They found the loss of a tumour suppressing protein called FBW7 blocks degradation of a protein called MCL1, which normally causes old or damaged cells to die.

According to one of the studies, led by Dr Ingrid Wertz and Dr Vishva Dixit of Genentech in California and published in the journal Nature, this mechanism is normally activated during mitotic arrest - the process in which cell division is blocked.

Some chemotherapeutic drugs intiate mitotic arrest by attacking cellular structures called microtubules.

"Microtubules play many roles, including movement of things within a cell," says study co-author Professor David Huang of the Walter and Eliza Hall Institute of Medical Research in Melbourne.

"They play an essential role in cell division, because you have to move all the different bits of furniture around in a coordinated, orchestrated process before the cells divide."

Huang says anti-microtubule agents like Taxol and vincristine interfere with the action of the microtubules. This disrupts the ability of the cells to divide normally, which can arrest the growth of a cancer.

"The problem that we found is that some tumours harbour mutations in FBW7 or they have lost FBW7," he says.

"So although the microtubules are disrupted, the message for the cells to die is not being sent. This is exactly what you don't want in the context of cancer treatment."

Huang says the discovery of this mechanism may allow an improved understanding of why some patients respond less well to drugs than others.

"If they also happen to have mutations in FBW7, their tumours would probably respond poorly to agents like Taxol," he says.

"The second thing is that understanding why that occurs has helped us identify that the culprit in this case is really MCL1, because it's hanging around too long keeping the cells alive.

"So we hope to add to the activity of drugs like these by adding in an agent that would target MCL1. That would be the most obvious route to go."
Second study confirms findings

In a second paper published today in Nature,Dr Wenyi Wei of the Dana-Farber Harvard Cancer Centre and colleagues, looked at a related family of cell suicide proteins, known as BCL2.

They also found there was loss of the FBW7 tumour suppressor in various cancers, including breast and colon cancer, and that treating these patients with antitubulin or BCL2-targeted cancer drugs may also be of limited value.

They add, analysing levels of FBW7 and MCL1 could offer a simple molecular diagnostic test to identify which patients are likely to benefit from these therapies.

Huang says the two groups started with different angles and reached the same point by chance.

"That's very satisfying, because it means that what's been discovered is more likely to be important and we've been able to confirm each other's findings."

Brain efficiency comes from parents
Backward bending light key to stealth
Signs of 'alien life' found in meteorites
Accurate blood test for Down's
Disaster volunteers at risk: study
Elephants smart as chimps, dolphins
Gadgets ruining people's sleep
Why skin doesn't dissolve in the bath
Astronomers find old heads in a young crowd
Paper leads to perfect beer head
Researchers locate brain's loudness map
Jamming may leave GPS in the wilderness
Pain washes guilt away
Quake could alter Tokyo risk: experts
Japan meltdown not like Chernobyl: expert
Dreamtime astronomers understood meteors
CERN restarts search for cosmic origins
Nuclear Contamination: What to Do
Bet-hedging 'key to natural selection'
Humans age same as other primates
US overdue, under-prepared for huge quake
Sperm's egg-seeking secrets revealed
Lasers to nudge space junk out harm's way
Researchers uncover gastro's sugary secret
Kepler probes inside swollen red giant
Randomness could 'improve democracy'
Moonageddon: Apocalypse not
Museum unveils Columbian mammoth
Ink-jet inspire scientists to make skin
Seaweed offers clues against malaria
Christchurch quakes may be connected
Solar storms pose risk to technology
Study finds fences thwart cane toad
Mobile phone alters brain activity
Sticky dots approved for clinical trial
Humans stink worse than other animals
Putting the bounce in carbon balls
Sulphur secrets uncovered
Cool laser makes atoms march in time
Hot flashes may be a sign of good heart
Scientists see the birth of a new planet
X-ray expectations change search methods
Eucalypt-harming fungus here to stay
Life elements came from outer space
Cricket wimps use perfume to find mates
Orphan planets could support life
Speech lights up visual cortex in blind
How the Sun loses its spots
Cancer resistance mechanism found
Fungus turns Amazonian ants into zombies
Tiny grains record solar system's infancy
Antarctic ice forming beneath glaciers
Visit Statistics